March 3, 2025
Shandong Qilu Stem Cell Engineering Co., Ltd. is first Cord Blood Bank in Mainland China to earn FACT AccreditationOMAHA, Neb. - Shandong Qilu Stem Cell Engineering Co., Ltd. (Shandong CBB) in Jinan City, Shandong, China, achieved internationally recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT), on February 18, 2025. Shandong CBB is the first and only cord blood bank in mainland China to receive this recognition. Under the leadership of Baijun Shen, MD, the bank has demonstrated its commitment to quality by meeting FACT’s Standards for cord blood collection, banking, and release for administration of both unrelated and related donations.
A spokesperson for Shandong CBB notes, “FACT accreditation represents a rigorous validation of our commitment to global standards of excellence in cellular therapy and cord blood banking. This achievement not only elevates the quality of healthcare services in China but also strengthens international trust in our capabilities. The accreditation process was a transformative journey for our team, reinforcing the importance of collaboration, precision, and continuous improvement. We hope this milestone inspires further advancements in the field across the region.”
With FACT-NetCord accreditation, Shandong CBB demonstrates its commitment to meeting the highest international standards in the field of cord blood banking.
Dr. Phyllis Warkentin, FACT Chief Medical Officer, states, “Achievement of accreditation by FACT is a significant accomplishment for the Shandong Qilu Stem Cell Engineering Co., Ltd., of Jinan City, the first Cord Blood Bank in mainland China to reach this milestone. Through this accreditation, Dr. Zhonghua Chu, Cord Blood Bank Director, Dr. Baijun Shen, and the staff at the Cord Blood Bank and Processing Facility, in conjunction with numerous collaborating hospitals that provide cell collections have demonstrated their dedication, resilience, and commitment to providing high quality products for the patients they serve. FACT recognizes this important accomplishment and the leadership of the Shandong Qilu Stem Cell Engineering Co., Ltd., in the field and the region.”
The Foundation for the Accreditation of Cellular Therapy (FACT) establishes and promotes high-quality standards for cellular therapy and cord blood banking worldwide.
